¼¼°èÀÇ Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­(2025³â)
Blood Glucose Monitoring Systems Global Market Report 2025
»óǰÄÚµå : 1702977
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,339,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,163,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,987,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 7.7%·Î 239¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº Æ÷µµ´ç µ¥ÀÌÅ͸¦ Ȱ¿ëÇÑ ¸ÂÃãÇü Ä¡·á °èȹ, ´ç´¢º´ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, °³¹ßµµ»ó±¹¿¡¼­ÀÇ Ã¤Åà Áõ°¡, ¿¬°á¼º °­È­, µ¥ÀÌÅÍ °ü¸®¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿þ¾î·¯ºí ±â±â ¹× ½º¸¶Æ® ±â±â¿ÍÀÇ ÅëÇÕ, ¼¾¼­ ±â¼úÀÇ ¹ßÀü, °³ÀÎ ¸ÂÃãÇü ÀÇ·á, ¿ø°Ý ÀÇ·á, ¿ø°Ý ¸ð´ÏÅ͸µ, ¿¬°á¼º ¹× µ¥ÀÌÅÍ °ü¸® °­È­ µîÀÌ ÀÖ½À´Ï´Ù.

´ç´¢º´ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´ ȯÀÚ Áõ°¡´Â ÁÂ½Ä »ýȰ½À°ü, ½Ä½À°ü Àå¾Ö, °í·ÉÈ­, À¯ÀüÀû ¼ÒÀÎ µîÀÇ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº Ç÷´çÀ» ÃßÀû ¹× °ü¸®Çϰí, Áúº´ °ü¸®¸¦ Áö¿øÇϸç, ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 12¿ù È£ÁÖ Á¤ºÎ ±â°üÀΠȣÁÖ Åë°èû¿¡ µû¸£¸é 2022³â¿¡´Â È£ÁÖÀÎÀÇ 5.3%, ¾à 130¸¸ ¸íÀÌ ´ç´¢º´ Áø´ÜÀ» ¹Þ¾ÒÀ¸¸ç, ³²¼º(5.8%)°ú ¿©¼º(4.9%)Àº ºñ½ÁÇÑ ºñÀ²·Î Áø´ÜÀ» ¹Þ¾Ò´Ù°í ÇÕ´Ï´Ù. ´ç´¢º´ À¯º´·üÀº ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ 75¼¼ À̻󿡼­´Â 18.7%¿¡ ´ÞÇϸç, 2Çü ´ç´¢º´ÀÌ 87.6%¸¦ Â÷ÁöÇØ °¡Àå ÈçÇÑ À¯ÇüÀÔ´Ï´Ù. ÇØ¿Ü¿¡¼­ ž °Í, ³«ÈÄµÈ Áö¿ª¿¡ »ç´Â °Í, Àå¾Ö¸¦ °¡Áö°í ÀÖ´Â °Í µîÀÇ ¿äÀÎÀÌ ´ç´¢º´ À¯º´·üÀÇ »ó½ÂÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ´ç´¢º´ À¯º´·ü Áõ°¡´Â Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Æ÷µµ´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ÇÏÀ̺긮µå Æó¼â ·çÇÁ ½Ã½ºÅÛ, ½º¸¶Æ®Æù ¿ëµµ µî ½Ç½Ã°£ µ¥ÀÌÅÍ ¾×¼¼½º ¹× °ü¸®¸¦ À§ÇÑ Ã·´Ü ±â¼ú¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ÇÏÀ̺긮µå Æó¼â ·çÇÁ ½Ã½ºÅÛÀº ½Ç½Ã°£ Ç÷´ç ÃøÁ¤°ªÀ» ±â¹ÝÀ¸·Î Àν¶¸° Åõ¿©¸¦ ÀÚµ¿È­ÇÏ¿© ´ç´¢º´ ȯÀÚÀÇ Ç÷´ç Á¶ÀýÀ» °­È­ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Á¦Á¶¾÷üÀÎ DexCom Inc.´Â 2024³â 2¿ù À¯·´ ¿©·¯ ±¹°¡¿¡¼­ Dexcom ONE+¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¹æ¼ö ¼¾¼­, ¿¬¼Ó Ç÷´ç ¸ð´ÏÅ͸µ¿ë Æ®·£½º¹ÌÅÍ, ½º¸¶Æ®Æù¿ë ¾Û µî ÷´Ü ¼¾¼­ ±â¼ú°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â´ÉÀ» ÅëÇÕÇÏ¿© »ç¿ëÀÚ»Ó¸¸ ¾Æ´Ï¶ó ÃÖ´ë 10¸í±îÁö Ãß°¡ÀûÀ¸·Î Ç÷´çÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϸç, °øÀ¯ ¸ð´ÏÅ͸µÀÌ ¿ëÀÌÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.

There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.

The blood glucose monitoring systems market research report is one of a series of new reports from The Business Research Company that provides blood glucose monitoring systems market statistics, including the blood glucose monitoring systems industry's global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The blood glucose monitoring systems market size has grown strongly in recent years. It will grow from $16.48 billion in 2024 to $17.8 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increased cases of diabetes globally, greater awareness leading to increased adoption of monitoring systems, supportive policies for diabetes management, improved access to healthcare facilities, and improved accuracy of glucose meters.

The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $23.99 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to tailored treatment plans using glucose data, increasing prevalence of diabetes, rising geriatric population, increasing adoption in developing regions, enhanced connectivity, and data management. Major trends in the forecast period include integration with wearable and smart devices, advancements in sensor technology, personalized medicine, telehealth, and remote monitoring, and enhanced connectivity and data management.

The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.

Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries in February 2024. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.

In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott's capabilities in glucose monitoring and insulin management solutions for diabetic patients.

Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Medtronic plc, Novo Nordisk A/S, B. Braun Melsungen AG, Terumo India Private Limited, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott India Limited, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Nipro India Corporation Private Limited., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc.

North America was the largest region in the blood glucose monitoring systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Glucose Monitoring Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood glucose monitoring systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood glucose monitoring systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood glucose monitoring systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Blood Glucose Monitoring Systems Market Characteristics

3. Blood Glucose Monitoring Systems Market Trends And Strategies

4. Blood Glucose Monitoring Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Blood Glucose Monitoring Systems Growth Analysis And Strategic Analysis Framework

6. Blood Glucose Monitoring Systems Market Segmentation

7. Blood Glucose Monitoring Systems Market Regional And Country Analysis

8. Asia-Pacific Blood Glucose Monitoring Systems Market

9. China Blood Glucose Monitoring Systems Market

10. India Blood Glucose Monitoring Systems Market

11. Japan Blood Glucose Monitoring Systems Market

12. Australia Blood Glucose Monitoring Systems Market

13. Indonesia Blood Glucose Monitoring Systems Market

14. South Korea Blood Glucose Monitoring Systems Market

15. Western Europe Blood Glucose Monitoring Systems Market

16. UK Blood Glucose Monitoring Systems Market

17. Germany Blood Glucose Monitoring Systems Market

18. France Blood Glucose Monitoring Systems Market

19. Italy Blood Glucose Monitoring Systems Market

20. Spain Blood Glucose Monitoring Systems Market

21. Eastern Europe Blood Glucose Monitoring Systems Market

22. Russia Blood Glucose Monitoring Systems Market

23. North America Blood Glucose Monitoring Systems Market

24. USA Blood Glucose Monitoring Systems Market

25. Canada Blood Glucose Monitoring Systems Market

26. South America Blood Glucose Monitoring Systems Market

27. Brazil Blood Glucose Monitoring Systems Market

28. Middle East Blood Glucose Monitoring Systems Market

29. Africa Blood Glucose Monitoring Systems Market

30. Blood Glucose Monitoring Systems Market Competitive Landscape And Company Profiles

31. Blood Glucose Monitoring Systems Market Other Major And Innovative Companies

32. Global Blood Glucose Monitoring Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Glucose Monitoring Systems Market

34. Recent Developments In The Blood Glucose Monitoring Systems Market

35. Blood Glucose Monitoring Systems Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â